JP2020527170A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527170A5
JP2020527170A5 JP2020522788A JP2020522788A JP2020527170A5 JP 2020527170 A5 JP2020527170 A5 JP 2020527170A5 JP 2020522788 A JP2020522788 A JP 2020522788A JP 2020522788 A JP2020522788 A JP 2020522788A JP 2020527170 A5 JP2020527170 A5 JP 2020527170A5
Authority
JP
Japan
Prior art keywords
aqueous
corresponds
solvent
alkoxylated
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020522788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527170A (ja
JP7186222B2 (ja
Filing date
Publication date
Priority claimed from EP17180380.2A external-priority patent/EP3424493A1/en
Application filed filed Critical
Publication of JP2020527170A publication Critical patent/JP2020527170A/ja
Publication of JP2020527170A5 publication Critical patent/JP2020527170A5/ja
Application granted granted Critical
Publication of JP7186222B2 publication Critical patent/JP7186222B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020522788A 2017-07-07 2018-07-06 安定なカンナビノイド組成物 Active JP7186222B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17180380.2A EP3424493A1 (en) 2017-07-07 2017-07-07 Stable cannabinoid compositions
EP17180380.2 2017-07-07
PCT/EP2018/068452 WO2019008179A1 (en) 2017-07-07 2018-07-06 STABLE CANNABINOID COMPOSITIONS

Publications (3)

Publication Number Publication Date
JP2020527170A JP2020527170A (ja) 2020-09-03
JP2020527170A5 true JP2020527170A5 (https=) 2021-07-26
JP7186222B2 JP7186222B2 (ja) 2022-12-08

Family

ID=59315425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020522788A Active JP7186222B2 (ja) 2017-07-07 2018-07-06 安定なカンナビノイド組成物

Country Status (10)

Country Link
US (1) US11752126B2 (https=)
EP (2) EP3424493A1 (https=)
JP (1) JP7186222B2 (https=)
KR (1) KR102680507B1 (https=)
CN (2) CN115120558A (https=)
AU (1) AU2018296679B2 (https=)
CA (1) CA3076750A1 (https=)
EA (1) EA202090177A1 (https=)
IL (1) IL271892B2 (https=)
WO (1) WO2019008179A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112915121A (zh) * 2019-12-06 2021-06-08 汉义生物科技(北京)有限公司 一种大麻素纳米胶束制剂及其制备方法
EP4275694A1 (de) 2022-05-13 2023-11-15 Solmic Biotech GmbH Verwendung von solubilisaten in erzeugnissen zur topischen anwendung
CN121532199A (zh) 2022-01-20 2026-02-13 索米尔生物技术有限公司 含有亲脂性活性成分的增溶物的可局部施用的组合物
DE202022000150U1 (de) 2022-01-20 2022-07-07 Solmic Bio Tech Gmbh Maske für medizinische oder kosmetische Zwecke mit mizellierten Extrakten
CN117986017B (zh) * 2023-11-27 2025-11-21 陕西师范大学 一种(Sm2-aYa)Ba4CuBiO10纳米粉体及用其改善单畴SmBCO超导块材性能的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788346B9 (en) * 1994-03-18 2007-02-14 Supernus Pharmaceuticals, Inc. Emulsified drug delivery systems
KR20070058028A (ko) * 1999-05-24 2007-06-07 소너스파머슈티칼즈인코포레이티드 난용성 약물용 에멀젼 부형제
US20030236236A1 (en) 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1480636B1 (en) * 2002-03-01 2007-04-18 Novagali Pharma SA Self emulsifying drug delivery systems for taxoids
US20080045559A1 (en) * 2003-10-29 2008-02-21 Sonus Pharmaceuticals, Inc. Tocopherol-modified therapeutic drug compounds
US20100235972A1 (en) 2005-07-28 2010-09-23 Guasch Michael N Fuel repellent compositions, fabrics and articles
US7402325B2 (en) * 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP2083799A1 (en) * 2006-10-20 2009-08-05 Solvay Pharmaceuticals B.V. Micellar nanoparticles of chemical substances
TWI392507B (zh) * 2006-10-20 2013-04-11 Solvay Pharm Bv 包埋的膠束奈米顆粒
HUE032158T2 (en) * 2008-10-31 2017-09-28 Univ Mississippi Process for the preparation of delta9-THC amino acid esters
US20120088829A1 (en) * 2010-09-29 2012-04-12 MyCell Holdings Limited Formulations of Ubiquinol and Resveratrol Esters
WO2013009928A1 (en) * 2011-07-11 2013-01-17 Organic Medical Research Cannabinoid formulations
US20140314672A1 (en) * 2013-04-06 2014-10-23 Igdrasol, Inc. Nanoparticle therapeutic agents, their formulations, and methods of their use
US9861611B2 (en) * 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
WO2017072774A1 (en) * 2015-10-29 2017-05-04 Solubest Ltd Pharmaceutical compositions for transmucosal delivery

Similar Documents

Publication Publication Date Title
JP2020527170A5 (https=)
IL271892B2 (en) Stable preparations containing cannabinoids
CN105112041B (zh) 耐受低pH值环境和较高矿化度的压裂液及其制备方法
JP2014508169A5 (https=)
CN111334264A (zh) 一种暂堵剂及其制备方法
MX2020001773A (es) Concentrado a base de aceite, metodo de preparacion del mismo y uso del mismo.
JP3835815B2 (ja) エンロフロキサシンの注射用もしくは注入用溶液
JP2020511440A5 (https=)
JP4321760B2 (ja) セメント硬化促進剤および方法
JP2008280502A5 (https=)
RU2019140915A (ru) Полилизиновое производное и его применение в композициях на основе твердого вещества
JP5679262B2 (ja) ゲル化剤及びゲル状組成物
JP5264096B2 (ja) パール光沢組成物の製造方法
DE1445591A1 (de) Verfahren zur Herstellung von Derivaten des 7-Oxy-2-oxo-1,2-dihydrochinolins
CN105647423A (zh) 一种双层胺类促进剂微胶囊及其制备方法
CN108618991B (zh) 无需peg的增溶剂及其制造方法
KR20150062895A (ko) 페닐링을 가지는 2종 화합물을 포함하는 화장료 조성물
AR036468A1 (es) Un metodo para preparar composiciones acondicionadoras de telas
JP4846641B2 (ja) セメント系固化材
JP2012198532A (ja) フォトレジスト製造用溶剤または溶剤組成物
JP3898237B2 (ja) クリ−ムはんだ
JPS62111650A (ja) ペ−スト状ゲル化剤の製造方法
JPH11100316A (ja) ゲル化した化粧用スティックのための有用な組成物
JP6370589B2 (ja) 水中油乳化組成物
JP5394165B2 (ja) 珪酸塩系土質安定用薬液、およびこれを用いた地盤安定化工法